MétaCan
Menu
Back to cohort
Record W4323812027 · doi:10.1080/21678421.2023.2173015

Clinical testing panels for ALS: global distribution, consistency, and challenges

2023· review· en· W4323812027 on OpenAlexaff
Allison A. Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, Jennifer A. Fifita, Lyndal Henden, Ingrid M. Keseler, Steven Lenz, Heather Marriott, Emily P. McCann, Maysen Mesaros, Sarah Opie-Martin, Emma Owens, Brooke Palus, Justyne Ross, Zhanjun Wang, Hannah L. White, Ammar Al‐Chalabi, Peter M. Andersen, Michael Benatar, Ian P. Blair, Johnathan Cooper‐Knock, Elizabeth A. Harrington, Jeannine M. Heckmann, John E. Landers, Cristiane Araújo Martins Moreno, Melissa Nel, Evadnie Rampersaud, Jennifer Roggenbuck, Guy A. Rouleau, Bryan J. Traynor, Marka van Blitterswijk, Wouter van Rheenen, Jan H. Veldink, Jochen H. Weishaupt, Luke Drury, Matthew B. Harms, Sali M.K. Farhan

Bibliographic record

VenueAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2023
Typereview
Languageen
FieldMedicine
TopicAmyotrophic Lateral Sclerosis Research
Canadian institutionsMontreal Neurological Institute and HospitalWestern UniversityMcGill University
FundersNational Health and Medical Research CouncilMedical Research CouncilNational Institutes of HealthPrinses Beatrix SpierfondsNational Human Genome Research InstituteALS AssociationNederlandse Organisatie voor Wetenschappelijk OnderzoekNational Institute for Health and Care ResearchMotor Neurone Disease AssociationMuscular Dystrophy AssociationJohns Hopkins UniversityMicrosoft ResearchMotor Neurone Disease AustraliaGlaxoSmithKline
KeywordsConsistency (knowledge bases)Computer scienceArtificial intelligence

Abstract

fetched live from OpenAlex

Objective: In 2021, the Clinical Genome Resource (ClinGen) amyotrophic lateral sclerosis (ALS) spectrum disorders Gene Curation Expert Panel (GCEP) was established to evaluate the strength of evidence for genes previously reported to be associated with ALS. Through this endeavor, we will provide standardized guidance to laboratories on which genes should be included in clinical genetic testing panels for ALS. In this manuscript, we aimed to assess the heterogeneity in the current global landscape of clinical genetic testing for ALS. Methods: We reviewed the National Institutes of Health (NIH) Genetic Testing Registry (GTR) and members of the ALS GCEP to source frequently used testing panels and compare the genes included on the tests. Results: 14 clinical panels specific to ALS from 14 laboratories covered 4 to 54 genes. All panels report on ANG, SOD1, TARDBP, and VAPB; 50% included or offered the option of including C9orf72 hexanucleotide repeat expansion (HRE) analysis. Of the 91 genes included in at least one of the panels, 40 (44.0%) were included on only a single panel. We could not find a direct link to ALS in the literature for 14 (15.4%) included genes. Conclusions: The variability across the surveyed clinical genetic panels is concerning due to the possibility of reduced diagnostic yields in clinical practice and risk of a missed diagnoses for patients. Our results highlight the necessity for consensus regarding the appropriateness of gene inclusions in clinical genetic ALS tests to improve its application for patients living with ALS and their families.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.984
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.455
GPT teacher head0.422
Teacher spread0.033 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designOther design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations17
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueAmyotrophic Lateral Sclerosis and Frontotemporal DegenerationSame topicAmyotrophic Lateral Sclerosis ResearchFrench-language works237,207